Mediation effects of diabetes and inflammation on the relationship of obesity to cognitive impairment in African Americans
- PMID: 35941823
- PMCID: PMC9639783
- DOI: 10.1111/jgs.17985
Mediation effects of diabetes and inflammation on the relationship of obesity to cognitive impairment in African Americans
Abstract
Background: Whether diabetes and adipokine-driven inflammation explain the association of obesity to cognitive impairment is unknown.
Methods: Structural equation models estimated the total effects of waist circumference on cognitive outcomes among African American participants cross-sectionally (index exam) and longitudinally. Total effects were deconstructed into direct pathways of waist circumference to cognitive impairment and indirect mediation pathways through leptin, soluble tumor necrosis factor receptor 2 (sTNFR2), and diabetes. Waist circumference, leptin, and sTNFR2 were standardized. Cognitive impairment was defined as MMSE <21 or a z-score < -1.5 standard deviation (SD). Incident cognitive impairment was defined among those without cognitive impairment at the index exam as follow-up MMSE<21, z- score < -1.5, MMSE decline >1 point/year, or z-score decline of >0.1 SD/year.
Results: Among 1008 participants (70% women, mean age 62.9 years, 14.5% with obesity, 26% with diabetes), 132 (13%) had baseline cognitive impairment. Each SD higher waist circumference was associated with higher odds of cognitive impairment, odds ratio (OR) = 1.63; (95% confidence interval: 1.17, 2.24), with mediating pathways explaining 65% of the total effect (58% from diabetes; 7% from inflammation). At follow-up (mean 6.8 years), 106 of 535 (19.8%) had developed cognitive impairment. Each SD higher waist circumference was associated with higher odds of developing cognitive impairment (OR = 1.87; 95%CI: 1.18, 2.74); the direct effect of waist circumference explained 37% of the total effect and mediating pathways explained 63% (61% from diabetes; 2% from inflammation), although individual pathways were not statistically supported in the smaller sample.
Conclusion: Diabetes, and to a lesser degree, adiposity-driven inflammation, appear to explain a substantial proportion of abdominal adiposity relationships with cognitive impairment. The impact of preventing and treating obesity on cognitive outcomes merits study.
Keywords: cardiovascular; cognitive aging; health disparities.
© 2022 The American Geriatrics Society.
Conflict of interest statement
Conflict of Interest
None
Figures
Similar articles
-
Adiposity, Change in Adiposity, and Cognitive Decline in Mid- and Late Life.J Am Geriatr Soc. 2017 Jun;65(6):1282-1288. doi: 10.1111/jgs.14786. Epub 2017 Mar 1. J Am Geriatr Soc. 2017. PMID: 28248413 Free PMC article.
-
Independent association of waist circumference with hypertension and diabetes in African American women, South Carolina, 2007-2009.Prev Chronic Dis. 2012;9:E105. doi: 10.5888/pcd9.110170. Epub 2012 May 24. Prev Chronic Dis. 2012. PMID: 22632742 Free PMC article.
-
Programming of Adiposity in Childhood and Adolescence: Associations With Birth Weight and Cord Blood Adipokines.J Clin Endocrinol Metab. 2017 Feb 1;102(2):499-506. doi: 10.1210/jc.2016-2342. J Clin Endocrinol Metab. 2017. PMID: 27841944 Free PMC article.
-
Higher Adiposity Is Associated With Slower Cognitive Decline in Hypertensive Patients: Secondary Analysis of the China Stroke Primary Prevention Trial.J Am Heart Assoc. 2017 Oct 10;6(10):e005561. doi: 10.1161/JAHA.117.005561. J Am Heart Assoc. 2017. PMID: 29018022 Free PMC article. Clinical Trial.
-
Association between adiposity levels and cognitive impairment in the Chilean older adult population.J Nutr Sci. 2019 Oct 9;8:e33. doi: 10.1017/jns.2019.24. eCollection 2019. J Nutr Sci. 2019. PMID: 31656624 Free PMC article.
Cited by
-
Exploring galectin-3's role in predicting mild cognitive impairment in type 2 diabetes and its regulation by miRNAs.Front Med (Lausanne). 2024 Jul 31;11:1443133. doi: 10.3389/fmed.2024.1443133. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39144658 Free PMC article.
-
Risk factors for cognitive impairment in middle-aged type 2 diabetic patients: a cross-sectional study.BMJ Open. 2024 Jan 2;14(1):e074753. doi: 10.1136/bmjopen-2023-074753. BMJ Open. 2024. PMID: 38167287 Free PMC article.
-
Validation of prevalent diabetes risk scores based on non-invasively measured predictors in Ghanaian migrant and non-migrant populations - The RODAM study.Public Health Pract (Oxf). 2023 Nov 23;6:100453. doi: 10.1016/j.puhip.2023.100453. eCollection 2023 Dec. Public Health Pract (Oxf). 2023. PMID: 38034345 Free PMC article.
-
A risk prediction model based on machine learning for early cognitive impairment in hypertension: Development and validation study.Front Public Health. 2023 Mar 9;11:1143019. doi: 10.3389/fpubh.2023.1143019. eCollection 2023. Front Public Health. 2023. PMID: 36969637 Free PMC article.
References
-
- Gaskin DJ, LaVeist TA, Richard P. Key Findings and Policy Recommendations: The Costs of Alzheimer’s and Other Dementias for African Americans. Report. The African American Network Against Alzheimer’s 2013:1–20. January 1, 2014. Accessed September 01, 2021. https://www.usagainstalzheimers.org/reports-research
-
- Stewart R, Masaki K, Xue Q-L, et al. A 32-Year Prospective Study of Change in Body Weight and Incident Dementia: The Honolulu-Asia Aging Study. Arch Neurol. January 1, 2005. 2005;62(1):55–60. doi:10.1001/archneur.62.1.55. doi:10.1001/archneur.62.1.55 - DOI - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS041558/NS/NINDS NIH HHS/United States
- 5U54GM115428/GM/NIGMS NIH HHS/United States
- 1R01AG066914/AG/NIA NIH HHS/United States
- R01 HL085571/HL/NHLBI NIH HHS/United States
- P20 GM121334/GM/NIGMS NIH HHS/United States
- R01 HL092577/HL/NHLBI NIH HHS/United States
- U01 HL054463/HL/NHLBI NIH HHS/United States
- R01 AG066914/AG/NIA NIH HHS/United States
- National Institutes of Health, and the Memory Impairment and Neurodegenerative Dementia (MIND) Center at the University of Mississippi Medical Center
- R01 AG054787/AG/NIA NIH HHS/United States
- R01 AG066010/AG/NIA NIH HHS/United States
- U54 GM115428/GM/NIGMS NIH HHS/United States
- R01 AG045255/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical